BIOMAT Database Logo BIOMAT Database Logo

Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox. 2023

Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008993 Monkeypox virus A species of ORTHOPOXVIRUS that is the etiological agent of MPOX (MONKEYPOX). MPXV Virus,Mpox Virus,Monkey Pox Virus,Monkeypoxvirus,MPXV Viruses,Monkey Pox Viruses,Monkeypox viruses,Monkeypoxviruses,Mpox Viruses,Virus, MPXV,Virus, Mpox,Viruses, MPXV,Viruses, Mpox
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012900 Smallpox Vaccine A VACCINIA VIRUS vaccine used for immunization against SMALLPOX. It is now recommended only for laboratory workers exposed to SMALLPOX VIRUS. Certain countries continue to vaccinate those in the military service. Rare complications most often associated with older generation smallpox vaccines include VACCINIA, secondary bacterial infections, and ENCEPHALOMYELITIS. Because MONKEYPOX VIRUS and SMALLPOX VIRUS are both ORTHOPOXVIRUS and are closely related smallpox vaccines provide effective CROSS-PROTECTION against MPOX (MONKEYPOX) (https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html). Monkey Pox Vaccine,Monkeypox Vaccine,Monkeypox and Smallpox Vaccine,Mpox Vaccine,Mpox and Smallpox Vaccine,Small Pox Vaccine,Smallpox and Monkeypox Vaccine,Smallpox and Mpox Vaccine,Vaccinia Vaccine,Vaccine, Monkey Pox,Vaccine, Monkeypox,Vaccine, Mpox,Vaccine, Small Pox,Vaccine, Smallpox,Vaccine, Vaccinia
D014615 Vaccinia The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine. Vaccinias
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox
D045908 Mpox (monkeypox) A viral disease infecting PRIMATES and RODENTS. Its clinical presentation in humans is similar to SMALLPOX including FEVER; HEADACHE; COUGH; and a painful RASH. It is caused by MONKEYPOX VIRUS and is usually transmitted to humans through BITES or via contact with an animal's BLOOD. Interhuman transmission is relatively low (significantly less than smallpox). Monkeypox,Monkey Pox,Mpoxs (monkeypox)

Related Publications

Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Modified vaccinia Ankara-Bavarian Nordic vaccine against mpox in children.
September 2023, The Lancet. Infectious diseases,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
January 2024, Vaccine,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox?
July 2023, The Lancet. Infectious diseases,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Facial nerve palsy as a possible adverse drug reaction of the modified vaccinia ankara-bavarian nordic (MVA-BN) smallpox vaccine: A pharmacovigilance analysis.
March 2023, The Journal of infection,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara Vaccine.
May 2024, Sexually transmitted diseases,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Progress in the evaluation of modified vaccinia Ankara vaccine against mpox.
November 2023, The Lancet. Infectious diseases,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine.
March 2023, JAMA,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Human Mpox Virus Infection After Receipt of Modified Vaccinia Ankara Vaccine-Reply.
March 2023, JAMA,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine.
November 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Lucy Deng, and Laura K Lopez, and Catherine Glover, and Patrick Cashman, and Renee Reynolds, and Kristine Macartney, and Nicholas Wood
Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines.
December 2023, Sexual health,
Copied contents to your clipboard!